Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18387931 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed STRADIVARIUS (Strategy To Reduce Atherosclerosis Development InVolving Administration of Rimonabant - the Intravascular Ultrasound Study)
Condition: Coronary Atherosclerosis
Interventions: Drug: Rimonabant (SR141716);   Drug: Placebo

Indicates status has not been verified in more than two years